i-Function, a leader in cognitive health solutions, has partnered with Lunavi to launch the LASSI-D (Loewenstein-Acevedo Scales of Semantic Interference and Learning – Digital) platform on July 7, 2025. This cloud-native, AI-enabled tool revolutionizes early detection of Mild Cognitive Impairment (MCI), a precursor to Alzheimer’s disease, by offering scalable, accessible screening for clinical and remote use.
i-Function and Lunavi introduce LASSI-D for early MCI detection.
Replaces costly tests with AI-driven, cloud-based screening.
Features high-accuracy voice recognition and multilingual support.
Built on Microsoft Azure with over 99% speech-to-text accuracy.
Backed by NIH-supported research for clinical validation.
Enables timely intervention for better cognitive health outcomes.
LASSI-D transforms traditional cognitive assessments by replacing time-intensive, paper-based tests with a digital platform. It leverages AI and high-accuracy voice recognition to detect subtle cognitive changes before conventional methods. “Early detection is key to managing cognitive decline, and with LASSI-D™, we’re addressing a major gap in current screening practices,” said Peter Kallestrup, Co-Founder and CEO of i-Function. The platform’s multilingual support and automated scoring make it accessible for diverse populations.
Lunavi’s expertise was pivotal in digitizing the original LASSI-L assessment. Using a secure Microsoft Azure environment and integrating advanced speech-to-text technologies from Google and Azure, Lunavi achieved over 99% voice recognition accuracy. “i Ascendion came to us with a compelling vision: to make early cognitive screening more accessible and effective,” said Sam Galeotos, CEO of Lunavi. Their agile development ensured rapid iteration and user feedback integration, creating a robust, scalable solution.
With only 16% of seniors receiving regular cognitive assessments and over 90% of the 7.4 million Americans aged 65+ with MCI undiagnosed, LASSI-D addresses a critical need. Its NIH-backed, clinically validated methodology enables healthcare professionals to identify at-risk individuals early, facilitating timely interventions that improve outcomes. The platform’s design supports both clinical settings and remote use, broadening access to effective screening.
The LASSI-D platform represents a significant advancement in cognitive health screening. By combining i-Function’s validated methodology with Lunavi’s cutting-edge technology, this partnership delivers a powerful tool to enhance early detection and support better management of cognitive decline, impacting millions globally.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.